Effect of fluid balance control in critically ill patients: Design of the stepped wedge trial POINCARE-2.


Journal

Contemporary clinical trials
ISSN: 1559-2030
Titre abrégé: Contemp Clin Trials
Pays: United States
ID NLM: 101242342

Informations de publication

Date de publication:
08 2019
Historique:
received: 29 03 2019
revised: 21 06 2019
accepted: 27 06 2019
pubmed: 2 7 2019
medline: 3 10 2020
entrez: 2 7 2019
Statut: ppublish

Résumé

A high number of recent studies have shown that a positive fluid balance is independently associated with impaired prognosis in specific populations of patients hospitalized in intensive care unit (ICU): acute kidney injury, acute respiratory distress syndrome (ARDS), sepsis, high risk surgery. However, to date, there is no evidence that control of fluid overload reduces mortality in critically ill patients. The main objective is to assess the efficacy of a strategy limiting fluid overload on mortality in unselected critically ill patients hospitalized in ICU. We hypothesized that a strategy based on a weight-driven recommendation of restricted fluid intake, diuretics, and ultrafiltration initiated from 48 h up to 14 days after admission in critically ill patients would reduce all-cause mortality as compared to usual care. We use a stepped wedge cluster randomized controlled trial combined with a quasi-experimental (before-and-after) study. Patients under mechanical ventilation, admitted since >48 h and < 72 h in ICU, and with no discharge planned for the next 24 h are eligible. A total of 1440 patients are expected to be enrolled in 12 ICUs. Sociodemographic and clinical data are collected at inclusion, and outcomes are collected during the follow-up. Primary outcome is all-cause mortality at 60 days after admission. Secondary outcomes are patients weight differences between admission and day7 (or day 14), 28-day, in-hospital, and 1-year mortality, end-organ damages, and unintended harmful events. Analyses will be held in intention-to-treat. If POINCARE-2 strategy proves effective, then guidelines on fluid balance control might be extended to all critically ill patients. Trial registration: ClinicalTrials.govNCT02765009.

Identifiants

pubmed: 31260794
pii: S1551-7144(19)30222-8
doi: 10.1016/j.cct.2019.06.020
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02765009']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-116

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Nelly Agrinier (N)

CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, F-54000 Nancy, France; Université de Lorraine, APEMAC, F-54000 Nancy, France. Electronic address: n.agrinier@chru-nancy.fr.

Alexandra Monnier (A)

CHRU Strasbourg, Nouvel Hôpital Civil, Service de Réanimation médicale, F-67000 Strasbourg, France.

Laurent Argaud (L)

Hospices civils de Lyon, Hôpital Edouard Herriot, Service de réanimation médicale, F-69000 Lyon, France.

Michel Bemer (M)

CHR Metz-Thionville, Service de Réanimation polyvalente, F-57000 Thionville, France.

Jean-Marc Virion (JM)

CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, F-54000 Nancy, France.

Camille Alleyrat (C)

CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, F-54000 Nancy, France.

Claire Charpentier (C)

CHRU-Nancy, Université de Lorraine, Service d'Anesthésie Réanimation chirurgicale, F-54000 Nancy, France.

Laurent Ziegler (L)

CH Verdun, Service d'anesthésie réanimation, F-55000 Verdun, France.

Guillaume Louis (G)

CHR Metz-Thionville, Service de Réanimation polyvalente, F-57000 Metz, France.

Cédric Bruel (C)

Groupe hospitalier Paris Saint-Joseph, Service de réanimation polyvalente, F-75000 Paris, France.

Matthieu Jamme (M)

CHI Poissy Saint-Germain, Service de Réanimation, F-78303 Poissy, France.

Jean-Pierre Quenot (JP)

CHU Dijon-Bourgogne, Service de Médecine Intensive-Réanimation, F-21000 Dijon, France.

Julio Badie (J)

Hôpital Nord Franche-Comté, Service de Réanimation médicale, F-90015 Belfort, France.

Francis Schneider (F)

CHU Strasbourg, Hôpital de Hautepierre, Service de Médecine Intensive Réanimation, INSERM U 1121, F-67000 Strasbourg, France.

Pierre-Edouard Bollaert (PE)

Université de Lorraine, CHRU-Nancy, Service de Médecine Intensive Réanimation, F-54000 Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH